These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10611198)

  • 1. Clinical efficacy of peritoneovenous shunting for the treatment of severe ovarian hyperstimulation syndrome.
    Koike T; Araki S; Minakami H; Ogawa S; Sayama M; Shibahara H; Sato I
    Hum Reprod; 2000 Jan; 15(1):113-7. PubMed ID: 10611198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes of the immunoglobulins in patients with severe ovarian hyperstimulation syndrome: efficacy of a novel treatment using peritoneo-venous shunt.
    Takamizawa S; Shibahara H; Taneichi A; Obara H; Fujiwara H; Ogawa S; Koike T; Idei S; Sato I
    Am J Reprod Immunol; 2002 Jan; 47(1):25-30. PubMed ID: 11883746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new effective method in the treatment of severe ovarian hyperstimulation syndrome.
    Zhang Q; Xia L; Gao G
    Iran J Reprod Med; 2012 Nov; 10(6):589-94. PubMed ID: 25246931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach.
    Balasch J; Fábregues F; Arroyo V; Jiménez W; Creus M; Vanrell JA
    Acta Obstet Gynecol Scand; 1996 Aug; 75(7):662-7. PubMed ID: 8822662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The ovarian hyperstimulation syndrome--diagnostic criteria, management procedures].
    Jakimiuk AJ; Grzybowski W; Zakrzewski J; Lewandowski P; Kozioł K
    Ginekol Pol; 2006 Nov; 77(11):885-92. PubMed ID: 17378130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dual Cycle and Dual Channel Regimen in the Treatment of Severe Ovarian Hyperstimulation Syndrome with Pregnancy].
    Cidan LM; Chen L; Zhang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 46(6):949-52. PubMed ID: 26867335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intensive care and treatment of severe ovarian hyperstimulation syndrome].
    Ma MY; Wen WB; Zhou LX; Yu TO; Fang B
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1212-4. PubMed ID: 15485803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative management of ovarian hyperstimulation syndrome.
    Morris RS; Miller C; Jacobs L; Miller K
    J Reprod Med; 1995 Oct; 40(10):711-4. PubMed ID: 8551473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome.
    Asch RH; Ivery G; Goldsman M; Frederick JL; Stone SC; Balmaceda JP
    Hum Reprod; 1993 Jul; 8(7):1015-20. PubMed ID: 8408480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis.
    Venetis CA; Kolibianakis EM; Toulis KA; Goulis DG; Papadimas I; Tarlatzis BC
    Fertil Steril; 2011 Jan; 95(1):188-96, 196.e1-3. PubMed ID: 20579987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
    Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
    Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study.
    Bellver J; Muñoz EA; Ballesteros A; Soares SR; Bosch E; Simón C; Pellicer A; Remohí J
    Hum Reprod; 2003 Nov; 18(11):2283-8. PubMed ID: 14585874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome.
    Al-Ramahi M; Leader A; Claman P; Spence J
    Hum Reprod; 1997 Dec; 12(12):2614-6. PubMed ID: 9455823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Paracentesis in Women with Severe Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study.
    Nouri K; Ott J; Lenart C; Walch K; Promberger R; Tempfer CB
    Gynecol Obstet Invest; 2016; 81(6):504-511. PubMed ID: 27399220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryo freezing for preventing Ovarian Hyperstimulation Syndrome.
    D'Angelo A; Amso N
    Cochrane Database Syst Rev; 2002; (2):CD002806. PubMed ID: 12076453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.
    Aboulghar M; Evers JH; Al-Inany H
    Cochrane Database Syst Rev; 2000; (2):CD001302. PubMed ID: 10796765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.